Compare WVE & TDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | TDW |
|---|---|---|
| Founded | 2012 | 1956 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.8B |
| IPO Year | 2015 | N/A |
| Metric | WVE | TDW |
|---|---|---|
| Price | $13.35 | $76.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 3 |
| Target Price | $31.47 | ★ $82.00 |
| AVG Volume (30 Days) | ★ 2.2M | 871.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,704,000.00 | N/A |
| Revenue This Year | N/A | $1.12 |
| Revenue Next Year | $119.93 | $5.56 |
| P/E Ratio | ★ N/A | $24.08 |
| Revenue Growth | ★ 149.43 | N/A |
| 52 Week Low | $5.28 | $31.17 |
| 52 Week High | $21.73 | $88.99 |
| Indicator | WVE | TDW |
|---|---|---|
| Relative Strength Index (RSI) | 47.54 | 53.45 |
| Support Level | $12.53 | $48.30 |
| Resistance Level | $14.56 | $82.00 |
| Average True Range (ATR) | 0.79 | 4.22 |
| MACD | 0.01 | -0.99 |
| Stochastic Oscillator | 23.84 | 13.40 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Tidewater Inc provides marine and transportation services to the offshore energy industry. The company's vessels and associated services support all phases of offshore crude oil and natural gas (also referred to as oil and gas) exploration activities, field development, production, and maintenance, as well as windfarm development and maintenance. Its services include towing and anchor handling for mobile offshore drilling units; transporting supplies and personnel necessary to sustain drilling, workovers, production activities, field abandonment, dismantlement, and restoration activities; and Others. The group manages its business through five segments including the Americas, Asia Pacific, Middle East, Europe/Mediterranean, and West Africa.